Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review
<p dir="ltr">With over 58 million cases and 6 million deaths by August 2022, the Coronavirus disease 2019 (COVID-19), causing severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2), has had an insurmountable impact on the world’s population. This is one of the worst health cris...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , , , , , |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513547745099776 |
|---|---|
| author | Nour Shaheen (14034758) |
| author2 | Abdelrahman Mohamed (8691030) Almoatazbellah Attalla (21397850) Rehab Adel Diab (17290211) Sarya Swed (12331238) Abdulqadir J Nashwan (17991280) Ala’ Abdala Rababah (15205093) Mahmoud Tarek Hefnawy (15415073) Youssef Soliman (19158097) Omar Ahmed Abdelwahab (15205090) Mariam Tarek Desouki (18833828) Abdulrhman Khaity (15415064) Ahmed Shaheen (15205087) Abdelraouf Ramadan (17687433) Mostafa Meshref (12590530) |
| author2_role | author author author author author author author author author author author author author author |
| author_facet | Nour Shaheen (14034758) Abdelrahman Mohamed (8691030) Almoatazbellah Attalla (21397850) Rehab Adel Diab (17290211) Sarya Swed (12331238) Abdulqadir J Nashwan (17991280) Ala’ Abdala Rababah (15205093) Mahmoud Tarek Hefnawy (15415073) Youssef Soliman (19158097) Omar Ahmed Abdelwahab (15205090) Mariam Tarek Desouki (18833828) Abdulrhman Khaity (15415064) Ahmed Shaheen (15205087) Abdelraouf Ramadan (17687433) Mostafa Meshref (12590530) |
| author_role | author |
| dc.creator.none.fl_str_mv | Nour Shaheen (14034758) Abdelrahman Mohamed (8691030) Almoatazbellah Attalla (21397850) Rehab Adel Diab (17290211) Sarya Swed (12331238) Abdulqadir J Nashwan (17991280) Ala’ Abdala Rababah (15205093) Mahmoud Tarek Hefnawy (15415073) Youssef Soliman (19158097) Omar Ahmed Abdelwahab (15205090) Mariam Tarek Desouki (18833828) Abdulrhman Khaity (15415064) Ahmed Shaheen (15205087) Abdelraouf Ramadan (17687433) Mostafa Meshref (12590530) |
| dc.date.none.fl_str_mv | 2022-10-31T06:00:00Z |
| dc.identifier.none.fl_str_mv | 10.2147/idr.s387551 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Could_the_New_BA_2_75_Sub-Variant_Cause_the_Emergence_of_a_Global_Epidemic_of_COVID-19_A_Scoping_Review/29116865 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Immunology Health sciences Epidemiology outbreak Omicron subvariant BA.2.75 COVID-19 |
| dc.title.none.fl_str_mv | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">With over 58 million cases and 6 million deaths by August 2022, the Coronavirus disease 2019 (COVID-19), causing severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2), has had an insurmountable impact on the world’s population. This is one of the worst health crises since 1918’s influenza pandemic. There are four subvariants of Omicron; BA.1, BA.1.1, BA.2 and BA.3. As a result of new mutations in its spike protein, most of which occur in its receptor binding site, the Omicron variant appears to be more transmissible and less resistant to vaccination and antibody response. Understanding Omicron’s virology and mutations is essential to developing diagnostic and therapeutic methods. A thorough assessment of control measures, as well as timely adjustment of control measures, requires addressing such issues as re-infection risk, vaccine response, booster vaccine doses, and the increased rate of Omicron infections. This review article aims to look at the current information about the different types of SARs-CoV-2, focusing on the new subtype BA.2.75.</p><h2>Other Information</h2><p dir="ltr">Published in: Infection and Drug Resistance<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.2147/idr.s387551" target="_blank">https://dx.doi.org/10.2147/idr.s387551</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_1da14a6d3edded86caf6c29ba751ce79 |
| identifier_str_mv | 10.2147/idr.s387551 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/29116865 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping ReviewNour Shaheen (14034758)Abdelrahman Mohamed (8691030)Almoatazbellah Attalla (21397850)Rehab Adel Diab (17290211)Sarya Swed (12331238)Abdulqadir J Nashwan (17991280)Ala’ Abdala Rababah (15205093)Mahmoud Tarek Hefnawy (15415073)Youssef Soliman (19158097)Omar Ahmed Abdelwahab (15205090)Mariam Tarek Desouki (18833828)Abdulrhman Khaity (15415064)Ahmed Shaheen (15205087)Abdelraouf Ramadan (17687433)Mostafa Meshref (12590530)Biomedical and clinical sciencesImmunologyHealth sciencesEpidemiologyoutbreakOmicronsubvariantBA.2.75COVID-19<p dir="ltr">With over 58 million cases and 6 million deaths by August 2022, the Coronavirus disease 2019 (COVID-19), causing severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2), has had an insurmountable impact on the world’s population. This is one of the worst health crises since 1918’s influenza pandemic. There are four subvariants of Omicron; BA.1, BA.1.1, BA.2 and BA.3. As a result of new mutations in its spike protein, most of which occur in its receptor binding site, the Omicron variant appears to be more transmissible and less resistant to vaccination and antibody response. Understanding Omicron’s virology and mutations is essential to developing diagnostic and therapeutic methods. A thorough assessment of control measures, as well as timely adjustment of control measures, requires addressing such issues as re-infection risk, vaccine response, booster vaccine doses, and the increased rate of Omicron infections. This review article aims to look at the current information about the different types of SARs-CoV-2, focusing on the new subtype BA.2.75.</p><h2>Other Information</h2><p dir="ltr">Published in: Infection and Drug Resistance<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.2147/idr.s387551" target="_blank">https://dx.doi.org/10.2147/idr.s387551</a></p>2022-10-31T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.2147/idr.s387551https://figshare.com/articles/journal_contribution/Could_the_New_BA_2_75_Sub-Variant_Cause_the_Emergence_of_a_Global_Epidemic_of_COVID-19_A_Scoping_Review/29116865CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/291168652022-10-31T06:00:00Z |
| spellingShingle | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review Nour Shaheen (14034758) Biomedical and clinical sciences Immunology Health sciences Epidemiology outbreak Omicron subvariant BA.2.75 COVID-19 |
| status_str | publishedVersion |
| title | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| title_full | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| title_fullStr | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| title_full_unstemmed | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| title_short | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| title_sort | Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review |
| topic | Biomedical and clinical sciences Immunology Health sciences Epidemiology outbreak Omicron subvariant BA.2.75 COVID-19 |